MX355770B - Composicion farmaceutica de ibuprofeno y tramadol para uso oftalmico. - Google Patents

Composicion farmaceutica de ibuprofeno y tramadol para uso oftalmico.

Info

Publication number
MX355770B
MX355770B MX2014012158A MX2014012158A MX355770B MX 355770 B MX355770 B MX 355770B MX 2014012158 A MX2014012158 A MX 2014012158A MX 2014012158 A MX2014012158 A MX 2014012158A MX 355770 B MX355770 B MX 355770B
Authority
MX
Mexico
Prior art keywords
tramadol
ibuprofen
pharmaceutical composition
composition
ophthalmological use
Prior art date
Application number
MX2014012158A
Other languages
English (en)
Other versions
MX2014012158A (es
Inventor
Martínez-Alzamora Fernando
Miguel Rizo Martínez José
Gómez Calvo Antonia
Sanz Menéndez Nuria
Muñoz Ruíz Ángel
Original Assignee
Farmalider Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmalider Sa filed Critical Farmalider Sa
Publication of MX2014012158A publication Critical patent/MX2014012158A/es
Publication of MX355770B publication Critical patent/MX355770B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pain & Pain Management (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención se refiere a una composición farmacéutica de ibuprofeno y tramadol para uso oftálmico. La composición resulta eficaz y segura para el tratamiento de la inflamación y/o el dolor ocular asociados a diversas enfermedades o estados patológicos que afectan a la zona ocular. En particular, la composición oftálmica de la invención está indicada, por ejemplo, para el tratamiento del dolor y/o la inflamación tras cirugía ocular.
MX2014012158A 2013-10-11 2014-10-08 Composicion farmaceutica de ibuprofeno y tramadol para uso oftalmico. MX355770B (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES201300963A ES2540151B1 (es) 2013-10-11 2013-10-11 Composición farmacéutica de ibuprofeno y tramadol para uso oftálmico

Publications (2)

Publication Number Publication Date
MX2014012158A MX2014012158A (es) 2015-05-27
MX355770B true MX355770B (es) 2018-04-30

Family

ID=51868157

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014012158A MX355770B (es) 2013-10-11 2014-10-08 Composicion farmaceutica de ibuprofeno y tramadol para uso oftalmico.

Country Status (13)

Country Link
US (1) US10292953B2 (es)
EP (1) EP2862565B1 (es)
AR (1) AR097997A1 (es)
BR (1) BR102014025307B1 (es)
CY (1) CY1120642T1 (es)
DK (1) DK2862565T3 (es)
ES (2) ES2540151B1 (es)
HR (1) HRP20181282T1 (es)
HU (1) HUE040093T2 (es)
MX (1) MX355770B (es)
PL (1) PL2862565T3 (es)
PT (1) PT2862565T (es)
RU (1) RU2694369C2 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITUB20153104A1 (it) * 2015-08-13 2017-02-13 Sooft Italia S P A Contrada Molino 17 68333 Montegiorgio Fm Composizione ed uso di collirio a base di inositolo per migliorare l'accomodazione visiva dei pazienti
ES2604816B1 (es) * 2015-09-09 2018-01-29 Farmalider, S.A. Composición farmacéutica de tramadol para uso oftálmico
RU2624901C2 (ru) * 2015-10-05 2017-07-07 Елизавета Геннадьевна Полунина Средство для аппликационной анестезии с антисептическими, оптикокератопротективными свойствами и способ его применения в офтальмологии
AR102172A1 (es) 2015-10-05 2017-02-08 Química Luar S R L Una composición farmacéutica bactericida y virucida
WO2018064648A1 (en) 2016-09-30 2018-04-05 Mati Therapeutics Inc. Ophthalmic drug sustained release formulation and uses thereof
HRP20230677T1 (hr) * 2019-07-09 2023-10-13 Farmalider, S.A. Kombinacija ibuprofena i tramadola za ublažavanje boli
TW202408467A (zh) * 2022-07-06 2024-03-01 日商樂敦製藥股份有限公司 眼科組成物

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB971700A (en) 1961-02-02 1964-09-30 Boots Pure Drug Co Ltd Anti-Inflammatory Agents
US3652589A (en) 1967-07-27 1972-03-28 Gruenenthal Chemie 1-(m-substituted phenyl)-2-aminomethyl cyclohexanols
GB1497044A (en) 1974-03-07 1978-01-05 Prodotti Antibiotici Spa Salts of phenyl-alkanoic acids
AU661723B2 (en) * 1991-10-30 1995-08-03 Mcneilab, Inc. Composition comprising a tramadol material and a non-steroidal anti-inflammatory drug
US20040224010A1 (en) * 2002-11-15 2004-11-11 Optime Therapeutics, Inc. Ophthalmic liposome compositions and uses thereof
MY135852A (en) * 2003-04-21 2008-07-31 Euro Celtique Sa Pharmaceutical products
CN1513442A (zh) * 2003-06-26 2004-07-21 昆明市延安医院 精氨酸-布洛芬混合物的制法和用途
MX2007015577A (es) * 2005-06-09 2008-02-25 Biolipox Ab Metodo y composiciones para el tratamiento de trastornos inflamatorios.
ES2651444T3 (es) * 2006-10-20 2018-01-26 Johnson & Johnson Consumer Inc. Combinación de acetaminofeno con ibuprofeno para el tratamiento del dolor
NZ581391A (en) * 2007-04-30 2012-06-29 Adolor Corp Compositions of (-)-e-10-oh-nt and methods for their synthesis and use
ES2356762B1 (es) * 2009-09-04 2011-11-24 Farmalider S.A. Composicion farmaceutica de ibuprofeno, tramadol y un aminoacido basico, procedimiento para su preparacion y utilizacion de la misma.
CN102058581B (zh) * 2010-11-30 2013-01-30 广东宏盈科技有限公司 一种眼用凝胶
CN107982211A (zh) * 2011-04-05 2018-05-04 奥普托索夫研究与发展有限公司 眼科治疗
ES2423866B1 (es) * 2012-02-22 2014-06-10 Farmalider, S.A. Composición farmaceútica de ibuprofeno y tramadol para inyección
GB201217522D0 (en) * 2012-10-01 2012-11-14 Sharma Anant ophthalmic therapy

Also Published As

Publication number Publication date
ES2540151A1 (es) 2015-07-08
RU2014140885A (ru) 2016-04-27
EP2862565B1 (en) 2018-05-23
CY1120642T1 (el) 2019-12-11
US10292953B2 (en) 2019-05-21
EP2862565A1 (en) 2015-04-22
DK2862565T3 (en) 2018-08-13
US20150105468A1 (en) 2015-04-16
AR097997A1 (es) 2016-04-27
ES2685023T3 (es) 2018-10-05
PL2862565T3 (pl) 2018-10-31
BR102014025307B1 (pt) 2021-11-03
PT2862565T (pt) 2018-10-16
RU2014140885A3 (es) 2018-06-14
MX2014012158A (es) 2015-05-27
RU2694369C2 (ru) 2019-07-12
ES2540151B1 (es) 2016-02-29
BR102014025307A2 (pt) 2015-09-29
HRP20181282T1 (hr) 2018-10-05
HUE040093T2 (hu) 2019-02-28

Similar Documents

Publication Publication Date Title
MX355770B (es) Composicion farmaceutica de ibuprofeno y tramadol para uso oftalmico.
EA201690212A1 (ru) Способы лечения или профилактики офтальмологических патологических состояний
HUE049237T2 (hu) Készítmények a bõr sérülései, rendellenességei és betegségei kezelési eljárásaiban történõ alkalmazásra
HK1246646A1 (zh) 用於治療糖尿病性視網膜病及其他眼科疾病的方法
MY171920A (en) Prevention and treatment of ocular conditions
WO2016113357A8 (en) Proteasome inhibitors for treating a disorder related to an accumulation of non-degraded abnormal protein or a cancer
NZ704247A (en) Compositions and treatment for eye diseases and disorders
MX2014005209A (es) Un medicamento para tratar la enfermedad del ojo anterior que comprende rebamipida y un agente de retencion de lagrimas.
IL273531A (en) Ophthalmic preparations containing latanoprost for use in the treatment of eye diseases
MX355853B (es) Composicion oftalmica para el tratamiento de infeccion ocular.
MX2018001918A (es) Aplicación cuantitativa periorbital de farmacos oftalmologicos.
WO2015048188A8 (en) Modified fibroblast growth factors for the treatment of ocular disorders
MX338323B (es) Formulacion topica oftalmica de peptidos.
EP3013425A4 (en) Treatment and diagnosis of ocular disease
ZA202002075B (en) Compounds, compositions and methods for treatment of eye disorders and skin diseases
EP3302464A4 (en) USE OF CANNABINOIDS IN THE TREATMENT OF INFLAMMATION AND / OR EYE PAIN
ZA202003944B (en) Ophthalmic topical composition comprising dobesilic acid for treating diseases of the posterior segment of the eye
PH12015501538A1 (en) Topical ocular analgesic agents
IL282898A (en) Ophthalmic compounds and methods for treating skin and eye diseases
IL280588A (en) Ophthalmic compositions and methods for treating eye problems and skin diseases
BR112017007102A2 (pt) uso de um medicamento no tratamento de patologias da córnea, composição oftálmica para uso de um medicamento no tratamento de doenças da córnea e método para preparar a composição oftálmica

Legal Events

Date Code Title Description
FG Grant or registration